Purple Book reference family · 351(a) biologic
Meningococcal Polysaccharide Vaccine, Group C (Menomune-C)
Meningococcal Polysaccharide Vaccine, Group C is an FDA-licensed reference biologic from Sanofi Vaccines US Inc..
351(a) biologicBLA 103923 Sanofi Vaccines US Inc.
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
1999
Reference product
Originator biologic
351(a)BLA 103923
Menomune-C Meningococcal Polysaccharide Vaccine, Group C
Sanofi Vaccines US Inc.
View full reference-product record- Approved
- Marketing
- Disc
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Protection horizon
Reference approval
Approval date of the reference Meningococcal Polysaccharide Vaccine, Group C product.
27 yr ago
Meningococcal Polysaccharide Vaccine, Group C: frequently asked questions
Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.
Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for Meningococcal Polysaccharide Vaccine, Group C.
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
